Streetbeat News

Products Services

GOOG

GOOGL

META

SNAP

Meta Platforms Inc has banned political campaigns and other regulated industries from using its new generative AI advertising products to prevent the spread of election misinformation. The move follows Meta's plans to expand access to AI-powered advertising tools. Alphabet Inc's Google launched similar AI ad tools, while TikTok and Snap Inc bar political ads. Meta's shares are trading 0.11% higher at $316.14.

Portfolio Pulse from Anusuya Lahiri

November 07, 2023 | 2:43 pm

VTYX

Ventyx Biosciences announced that the Phase 2 trial of VTX958 in plaque psoriasis did not meet the internal target, which does not support further development of VTX958 in psoriasis. This has led to a decrease in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 2:32 pm

EDRY

EuroDry has announced the delivery of M/V Maria, an eco ultramax drybulk carrier. The company has also arranged a sustainability-linked loan of $11M with Eurobank to partly finance the acquisition.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 2:29 pm

VTYX

Ventyx Biosciences Inc (NASDAQ:VTYX) has announced disappointing results from the Phase 2 trial of VTX958 in patients with moderate to severe plaque psoriasis. Despite achieving statistical significance on the primary endpoint and all key secondary endpoints, the efficacy observed did not meet the company's internal target. As a result, Ventyx Biosciences will terminate ongoing activities in the Phase 2 plaque psoriasis trial and the ongoing Phase 2 trial of VTX958 in psoriatic arthritis. The company's stock is down 78.70% in premarket trading.

Portfolio Pulse from Vandana Singh

November 07, 2023 | 2:23 pm

CDIO

Family Medicine Specialists (FMS) is implementing Cardio Diagnostics Holdings, Inc.'s (NASDAQ:CDIO) solutions to identify patients at risk for coronary heart disease. The initiative will use Cardio Diagnostics' advanced blood-based epigenetic-genetic tests to risk stratify FMS' patient population. FMS will implement Cardio Diagnostics' heart attack risk assessment test, Epi+Gen CHD, in at least 1,200 patients with CHD risk factors with BlueCross BlueShield health plans.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 2:09 pm

IBRX

ImmunityBio, Inc. (IBRX) has announced new data showing promising anti-tumor activity of its Memory Cytokine-Enriched Natural Killer cells (M-ceNK) in small cell lung cancer and other types of neuroendocrine tumors. The M-ceNK cells use the patient's own NK cells, enriched with ImmunityBio's IL-15 superagonist N-803, to recognize and kill cancer targets. The findings were presented at the annual meeting of the Society for Immunotherapy of Cancer (SITC).

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 2:07 pm

ACHR

Archer Aviation has purchased several units of BETA's interoperable and multimodal fast-charging system for the electric aviation industry. The collaboration aims to accelerate the adoption of an interoperable charging system across the industry, following the standards outlined by the General Aviation Manufacturers Association (GAMA). BETA's charging systems are already in use at 14 locations across the eastern U.S, with plans to install them at another 55 locations and at Archer's flight test facilities in California.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 2:06 pm

SSYS

Toyota has signed an agreement to be the first customer to purchase the new Stratasys F3300 3D printer. The F3300 will be used for new production support, including parts and fixtures, and also for prototyping applications. The printer is capable of producing complex, high-precision parts and is expected to lower cost-per-part by up to 25 percent, print up to two times faster than any other FDM printers for production, and have 25 percent increased accuracy.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 2:06 pm

MODN

Model N (NYSE:MODN) has announced new product enhancements to help pharma manufacturers manage regulatory, compliance, and discounting challenges. The enhancements relate to 340B, the Inflation Reduction Act (IRA), and global pricing. The company has also added IRA-specific master data attributes to its product master data, and introduced Country Rules as a Service to its Global Pricing Management product to help pharma companies comply with evolving regulations worldwide.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 2:06 pm

CIEN

Telenet, a Liberty Global company and the largest provider of cable broadband services in Belgium, is deploying Ciena's (NYSE:CIEN) optical and network management solutions to support its network expansion across Belgium. Ciena is upgrading Telenet's optical network with a suite of industry leading solutions, including 6500 Reconfigurable Line System (RLS), WaveLogic™ 5 Nano (WL5n) 400G QSFP-DD coherent pluggable transceivers, Waveserver 5 interconnect platform, and Manage, Control and Plan (MCP) domain controller.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 2:05 pm